Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacopo Giuliani

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 7, 2022
Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastasesJacopo Giuliani
Journal of Palliative Medicine|November 30, 2013
Palliative surgery in the multidisciplinary management of advanced ovarian cancerJacopo Giuliani
Clinical Colorectal Cancer|December 31, 2021
Trifluridine/Tipiracil in Combination with Bevacizumab in First-Line for Metastatic Colorectal Cancer: A Way Forward. A Point of View Based on Cost-EffectivenessJacopo Giuliani
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 14, 2022
Cost-effectiveness of biweekly cetuximab plus chemotherapy in first-line treatment for RAS wild-type metastatic colorectal cancerJacopo Giuliani
Journal of Gastrointestinal Cancer|February 26, 2013
Intraperitoneal hyperthermic chemotherapy: which drugs?Jacopo Giuliani
Journal of Gastrointestinal Cancer|February 4, 2014
The coexistence of second and third malignancies in adult-onset cancer patientsJacopo Giuliani
Journal of Gastrointestinal Cancer|September 12, 2012
Primary malignant fibrous histiocytoma of Vater's Papilla: first reported caseJacopo Giuliani
Medical Oncology (Northwood, London, England)|July 10, 2012
A severe delayed infusion reaction induced by trastuzumab: a life-threatening conditionJacopo Giuliani
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 24, 2021
Cost-effectiveness of denosumab in preventing skeletal-related events in bone metastasesJacopo Giuliani
Current Opinion in Oncology|June 17, 2020
Cost-effectiveness of newer regimens for the prophylaxis of chemotherapy-induced nausea and vomiting: review of the literature and real-world dataJacopo Giuliani, Andrea Bonetti
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 7, 2022
Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastasesJacopo Giuliani
Journal of Palliative Medicine|November 30, 2013
Palliative surgery in the multidisciplinary management of advanced ovarian cancerJacopo Giuliani
Clinical Colorectal Cancer|December 31, 2021
Trifluridine/Tipiracil in Combination with Bevacizumab in First-Line for Metastatic Colorectal Cancer: A Way Forward. A Point of View Based on Cost-EffectivenessJacopo Giuliani
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 14, 2022
Cost-effectiveness of biweekly cetuximab plus chemotherapy in first-line treatment for RAS wild-type metastatic colorectal cancerJacopo Giuliani
Journal of Gastrointestinal Cancer|February 26, 2013
Intraperitoneal hyperthermic chemotherapy: which drugs?Jacopo Giuliani
Journal of Gastrointestinal Cancer|February 4, 2014
The coexistence of second and third malignancies in adult-onset cancer patientsJacopo Giuliani
Journal of Gastrointestinal Cancer|September 12, 2012
Primary malignant fibrous histiocytoma of Vater's Papilla: first reported caseJacopo Giuliani
Medical Oncology (Northwood, London, England)|July 10, 2012
A severe delayed infusion reaction induced by trastuzumab: a life-threatening conditionJacopo Giuliani
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 24, 2021
Cost-effectiveness of denosumab in preventing skeletal-related events in bone metastasesJacopo Giuliani
Current Opinion in Oncology|June 17, 2020
Cost-effectiveness of newer regimens for the prophylaxis of chemotherapy-induced nausea and vomiting: review of the literature and real-world dataJacopo Giuliani, Andrea Bonetti
Pageof 14